Development and dissemination of the national strategic action plan for reducing inappropriate polypharmacy in older Australians
- PMID: 33572018
- DOI: 10.1111/imj.15155
Development and dissemination of the national strategic action plan for reducing inappropriate polypharmacy in older Australians
Abstract
A cohesive, national approach is needed to address inappropriate polypharmacy in older adults and promote deprescribing. We describe the dissemination of the Quality Use of Medicines to Optimise Ageing in Older Australians: Recommendations for a National Strategic Action Plan to Reduce Inappropriate Polypharmacy, and the initiatives taken to date that align with, and assist in operationalising this plan.
Keywords: EVOLVE; deprescribing; inappropriate polypharmacy; older adult.
© 2021 Royal Australasian College of Physicians.
Similar articles
-
Inappropriate polypharmacy management versus deprescribing: A review on their relationship.Basic Clin Pharmacol Toxicol. 2024 Jan;134(1):6-14. doi: 10.1111/bcpt.13920. Epub 2023 Jul 11. Basic Clin Pharmacol Toxicol. 2024. PMID: 37350370 Review.
-
Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens.Lancet Healthy Longev. 2021 May;2(5):e290-e300. doi: 10.1016/S2666-7568(21)00054-4. Lancet Healthy Longev. 2021. PMID: 36098136 Review.
-
The value of deprescribing in older adults with dementia: a narrative review.Expert Rev Clin Pharmacol. 2021 Nov;14(11):1367-1382. doi: 10.1080/17512433.2021.1961576. Epub 2021 Aug 19. Expert Rev Clin Pharmacol. 2021. PMID: 34311630 Review.
-
Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.Eur Geriatr Med. 2023 Dec;14(6):1195-1209. doi: 10.1007/s41999-023-00872-0. Epub 2023 Oct 9. Eur Geriatr Med. 2023. PMID: 37812379 Free PMC article.
-
GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.J Am Geriatr Soc. 2020 Feb;68(2):403-410. doi: 10.1111/jgs.16273. Epub 2019 Dec 2. J Am Geriatr Soc. 2020. PMID: 31792947 Clinical Trial.
References
-
- Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med 2015; 175: 827-34.
-
- RACP. EVOLVE The Royal Australasian College of Physicians 2020 [cited 2020 Dec 16]. Available from URL: https://evolve.edu.au/
-
- Quality Use of Medicines to Optimise Ageing in Older Australians: Recommendations for a National Strategic Action Plan to Reduce Inappropriate Polypharmacy. Sydney; 2018 [cited 2020 Dec 16]. Available from URL: https://www.sydney.edu.au/medicine/cdpc/resources/quality-use-of-medicin...
-
- Shaw B, Chisholm O. Australia's National Medicines Policy is outdated and in need of review. Med J Aust 2019; 211: 252-4.e1.
-
- McLachlan AJ, Aslani P. National Medicines Policy 2.0: a vision for the future. Aust Prescr 2020; 43: 24-6.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources